🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/12/2004 29,91 30,52 29,90 30,52 +1,49% 2,04% 19.363.896
20/12/2004 29,84 30,24 29,83 30,07 -0,25% 1,38% 19.026.440
17/12/2004 29,43 30,33 28,98 30,14 -0,63% 4,60% 40.023.330
16/12/2004 29,15 30,38 29,12 30,33 +4,30% 4,32% 32.315.709
15/12/2004 28,58 29,12 28,47 29,08 +2,90% 2,27% 32.830.172
14/12/2004 27,72 28,28 27,72 28,26 +1,96% 2,03% 17.751.338
13/12/2004 27,43 27,73 27,42 27,72 +1,08% 1,11% 12.639.928
10/12/2004 27,68 27,91 27,02 27,42 +0,04% 3,21% 9.393.853
09/12/2004 27,38 27,53 27,19 27,41 +0,14% 1,25% 13.043.094
08/12/2004 26,96 27,40 26,91 27,38 +2,87% 1,84% 21.279.850
07/12/2004 26,86 26,96 26,58 26,61 -0,82% 1,39% 13.926.348
06/12/2004 27,27 27,34 26,82 26,83 -1,95% 1,89% 14.705.641
03/12/2004 27,29 27,59 27,10 27,37 +0,28% 1,78% 17.109.543
02/12/2004 26,46 27,36 26,29 27,29 +3,17% 4,04% 21.461.782
01/12/2004 26,57 26,60 26,07 26,45 -1,07% 2,01% 16.440.081
30/11/2004 26,39 26,84 26,39 26,74 +1,26% 1,70% 16.954.439
29/11/2004 26,64 26,81 26,38 26,40 -0,11% 1,61% 13.866.717
26/11/2004 26,11 26,50 26,10 26,43 +1,76% 1,54% 7.689.281
24/11/2004 26,00 26,15 25,87 25,97 +0,30% 1,06% 12.081.344
23/11/2004 25,89 25,96 25,75 25,90 +0,04% 0,81% 12.102.304
22/11/2004 25,88 26,15 25,75 25,89 +0,04% 1,51% 13.626.515
19/11/2004 25,95 26,19 25,76 25,88 -0,88% 1,65% 14.523.813
18/11/2004 26,02 26,24 25,65 26,11 +0,07% 2,27% 14.841.462
17/11/2004 26,38 26,53 26,05 26,09 -0,51% 1,81% 14.607.234
16/11/2004 26,00 26,48 25,96 26,22 +1,44% 1,98% 20.989.239
15/11/2004 25,24 26,09 25,19 25,85 +2,42% 3,55% 25.266.756
12/11/2004 25,00 25,45 25,00 25,24 +1,15% 1,79% 19.452.242
11/11/2004 25,33 25,38 24,92 24,95 -0,98% 1,81% 20.317.576
10/11/2004 24,43 25,64 24,43 25,20 +1,58% 4,96% 35.614.498
09/11/2004 24,65 24,99 24,56 24,81 -2,15% 1,74% 45.119.858